Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Reducing CD8+ T cell growth can stabilize alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

IL-17 and certain immune cells are linked to more severe alopecia areata.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

IL-27 can prevent hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.